Standout Papers

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 2013 2026 2017 2021 2.5k
  1. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (2013)
    Benjamin M. Scirica, Deepak L. Bhatt et al. New England Journal of Medicine
  2. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020)
    Deepak L. Bhatt, Michael Szarek et al. New England Journal of Medicine
  3. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014)
    Benjamin M. Scirica, Eugene Braunwald et al. Circulation
  4. Sodium Glucose Cotransporter-2 Inhibition in Heart Failure (2017)
    Yuliya Lytvyn, Petter Bjornstad et al. Circulation

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 95 standout
Sub-graph 1 of 14

Citing Papers

Long COVID: a clinical update
2024 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
4 intermediate papers

Works of Jacob A. Udell being referenced

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities
2021
Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists
2016
and 4 more

Author Peers

Author Last Decade Papers Cites
Jacob A. Udell 3000 5196 2305 158 8.4k
Russell Scott 1837 5727 4665 237 11.1k
Judith Hsia 3393 4501 2726 147 11.6k
B Charbonnel 1174 6864 2763 236 9.4k
Avivit Cahn 1944 7371 2872 111 8.8k
Göran Walldius 1993 2999 2994 184 9.0k
Hanna E. Bloomfield 2002 3767 4601 81 8.3k
Michael Szarek 2204 3156 3713 120 7.0k
David Preiss 2052 4176 3180 103 8.1k
Ian F. Godsland 1961 4205 1414 175 9.0k
Sanjoy K. Paul 1391 7641 1936 100 10.3k

All Works

Loading papers...

Rankless by CCL
2026